1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological MalignanciesDisease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasmNot yet recruitingPhase 12026-04-16NCT07532746